Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: GSK1070806
DRUG: Placebo

Sponsor

GlaxoSmithKline